Biosyent Inc (RX) Common NPV
Sell:11.68 CADBuy:11.94 CAD
0.25 CAD
(2.14%)
- This stock can be held in a
Stocks and Shares ISA0.25 CAD
(2.14%)0.25 CAD
(2.14%)Company Information
About this company
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., sources, acquires or in-licenses and further develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary, operates the Company’s business marketing biologically and health friendly non-chemical insecticides. The Company’s products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia. FeraMAX Pd Maintenance 45 is a chewable supplement with iron plus vitamin B12 and vitamin C for the prevention of iron deficiency anemia.
Key people
Key facts
- EPICRX
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINCA0906901081
- Market capCA$133.00m
- Employees0
- Shares in issue11.69m
- ExchangeTSX Venture Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.